Prognostic Significance of Plasma High-Sensitivity C-Reactive Protein in Patients With Hypertrophic Cardiomyopathy [Heart Failure]

BackgroundElevated high‐sensitivity C‐reactive protein (hsCRP) has been associated with increased risks of adverse outcomes of various cardiovascular diseases. The relationship between hsCRP and the prognosis of hypertrophic cardiomyopathy remains to be evaluated.Methods and ResultsThe study used an observational cohort methodology. A total of 490 patients were enrolled in the Fuwai Hospital from 2001 to 2011 and were followed for 3.7±2.0 years. According to the risk category of hsCRP, subjects in the high hsCRP group (>3.0 mg/L) had a higher risk of developing adverse events than the low hsCRP group (

Source: JAHA:Journal of the American Heart Association - February 2, 2017 Category: Cardiology Authors: Zhu, L., Zou, Y., Wang, Y., Luo, X., Sun, K., Wang, H., Jia, L., Liu, Y., Zou, J., Yuan, Z., Hui, R., Kang, L., Song, L., Wang, J. Tags: Cardiomyopathy, Hypertrophy Original Research Source Type: research